Emerald Wealth Partners' Q4 Letter Details Revvity Exit and Alphabet-Driven Gains

Overview

• In 2025 the Growth Equity Strategy returned +3.1% gross and +3.0% net, with year-to-date performance reported at +16.7% gross and +16.0% net.
• Emerald used a Q4 rebound to sell Revvity, citing limited business visibility and management’s failure to deliver on key strategic elements.
• Alphabet and Thermo Fisher were meaningful contributors, with Alphabet benefiting from advances in its Gemini large language model and rising interest in its TPU chips.
• As of March 13, 2026, Revvity closed at $85.62 with a 52-week loss of 22.57% while Alphabet closed at $301.46 with a 52-week gain of 80.98%, and hedge-fund holdings increased into Q4 for both names (RVTY 22→35; GOOG 186→203).
• The letter also describes adding back to Oracle after a 38% slide, viewing valuation as attractive despite plans to take on $80–100 billion in additional debt for AI data center buildout.